Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 29.74
+1.37 (4.83%)
At close: Mar 27, 2026
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 12.07 billion as of March 27, 2026. Its market cap has increased by 118.39% in one year.
Market Cap
12.07B
Enterprise Value
12.25B
Revenue
704.16M
Ranking
n/a
PE Ratio
542.73
Stock Price
29.74
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 12.07B, a decrease of -25.38%. That is a compound annual growth rate of -5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 12.07B | 17.21% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 13.26B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| Beijing Hotgen Biotech | 11.74B |
| Chengdu Easton Biopharmaceuticals | 11.57B |
| InventisBio | 11.56B |